St. Jude Medical CardioMEMS HF System Showcased at Premier, Inc.'s 2015 'Innovation Celebration' Breakthroughs Conference

ST. PAUL, Minn.--(BUSINESS WIRE)--

St. Jude Medical, Inc. STJ, a global medical device company, today announced the CardioMEMS^™ HF System was named as one of the medical innovations at the Premier, Inc.'s 2015 Breakthroughs Conference and Exhibition in National Harbor, Md. The event recognizes significant advances in health care while highlighting medical industry suppliers committed to innovation and improving patient outcomes.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20150624005827/en/

The CardioMEMS HF System is being showcased on June 24 during the conference's seventh annual Innovation Celebration. The CardioMEMS HF System uses a miniaturized, wireless monitoring sensor that is implanted in the pulmonary artery (PA) during a minimally invasive procedure to directly measure PA pressure.

The system allows patients to transmit the PA pressure data from their homes to their health care providers, who then manage appropriate medication changes to reduce the likelihood of hospitalization. The CardioMEMS HF System is the first and only FDA-approved HF monitor, that, when used by physicians to monitor their HF patients, has been shown to significantly reduce HF hospital admissions and improve the quality of life in NYHA Class III patients.

"St. Jude Medical shares Premier's commitment to providing valuable products to our alliance members that are safe, high-quality and cost-effective," said Durral R. Gilbert, president of supply chain services at Premier, Inc. "We believe these innovations can benefit providers as they work to transform health care."

Clinicians and other health care system members of Premier, Inc. selected the CardioMEMS HF System to be showcased at the Innovation Celebration due to its uniqueness, ability to have an impact on unmet clinical needs and potential to improve heart failure (HF) patients' care.

"We are honored that Premier, Inc. recognized St. Jude Medical as one of the providers of a breakthrough technology and a company committed to innovation for improved patient outcomes," said Joel D. Becker, president of the St. Jude Medical Americas Division. "St. Jude Medical is excited to offer physicians a unique, proactive management tool like the CardioMEMS HF System that sets a new standard of care for the management of heart failure."

The CardioMEMS HF System is supported by strong clinical evidence, including data from the CHAMPION ("CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Patients") trial published in The Lancet. The CHAMPION trial evaluated the overall safety and effectiveness of the CardioMEMS HF System for New York Heart Association (NYHA) Class III HF patients who had been hospitalized for HF in the previous 12 months. The CHAMPION trial demonstrated a 37 percent reduction in HF hospitalizations during an average follow-up duration of 15 months. Additionally, a new retrospective data analysis from the CHAMPION trial showing that HF patients with reduced ejection fraction on optimal doses of guideline directed medical therapy managed by PA pressure monitoring with the CardioMEMS HF System had a 57 percent reduction in mortality compared with currently defined best practices.

For more detailed information, including a video of the CardioMEMS HF System, visit:
www.premierinc.com/breakthroughs/innovation-celebration-2015.

About Premier, Inc.
Premier, Inc. is a leading healthcare improvement company, uniting an alliance of approximately 3,400 U.S. hospitals and 110,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost. Premier, a Malcolm Baldrige National Quality Award recipient, plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier's news and investor sites on www.premierinc.com.

About St. Jude Medical
St. Jude Medical is a global medical device manufacturer dedicated to transforming the treatment of some of the world's most expensive epidemic diseases. The company does this by developing cost-effective medical technologies that save and improve lives of patients around the world. Headquartered in St. Paul, Minn., St. Jude Medical has four major clinical focus areas that include cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. For more information, please visit sjm.com or follow us on Twitter @SJM_Media.

Forward-Looking Statements
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such forward-looking statements include the expectations, plans and prospects for the Company, including potential clinical successes, anticipated regulatory approvals and future product launches, and projected revenues, margins, earnings and market shares. The statements made by the Company are based upon management's current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include market conditions and other factors beyond the Company's control and the risk factors and other cautionary statements described in the Company's filings with the SEC, including those described in the Risk Factors and Cautionary Statements sections of the Company's Annual Report on Form 10-K for the fiscal year ended January 3, 2015 and Quarterly Report on Form 10-Q for the fiscal quarter ended April 4, 2015. The Company does not intend to update these statements and undertakes no duty to any person to provide any such update under any circumstance.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150624005827/en/